Information: Detta är inte den senaste versionen av datamodellen. Du hittar en versionsöversikt till vänster under versioner. Den senaste versionen hittar du här.
Information:
Fel:
ID
37093
Beskrivning
The Efficacy and Safety of Fang yi Qing Feng Shi Granules in Subjects With Rheumatoid Arthritis; ODM derived from: https://clinicaltrials.gov/show/NCT02029599
Länk
https://clinicaltrials.gov/show/NCT02029599
Nyckelord
Versioner (2)
- 2019-07-03 2019-07-03 -
- 2019-07-03 2019-07-03 -
Rättsinnehavare
See clinicaltrials.gov
Uppladdad den
3 juli 2019
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Rheumatoid Arthritis NCT02029599
Eligibility Rheumatoid Arthritis NCT02029599
- StudyEvent: Eligibility
Similar models
Eligibility Rheumatoid Arthritis NCT02029599
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Rheumatoid Arthritis
Item
1. subjects have the diagnosis of rheumatoid arthritis in active state.
boolean
C0003873 (UMLS CUI [1])
Arthralgia Diagnosis Traditional Chinese Medicine | Other Coding
Item
2. subjects have the traditional chinese medicine (tcm) diagnosis ofarthralgic syndrome with the sign of dampness obstructing connecting vessel。
boolean
C0003862 (UMLS CUI [1,1])
C0011900 (UMLS CUI [1,2])
C0025124 (UMLS CUI [1,3])
C3846158 (UMLS CUI [2])
C0011900 (UMLS CUI [1,2])
C0025124 (UMLS CUI [1,3])
C3846158 (UMLS CUI [2])
Disease-Modifying Antirheumatic Drugs To be stopped | Glucocorticoids To be stopped
Item
3. subjects must stop the medicine at least three month，which is diseases modifying anti-rheumatic drugs(including glucocorticoids).
boolean
C0242708 (UMLS CUI [1,1])
C1272691 (UMLS CUI [1,2])
C0017710 (UMLS CUI [2,1])
C1272691 (UMLS CUI [2,2])
C1272691 (UMLS CUI [1,2])
C0017710 (UMLS CUI [2,1])
C1272691 (UMLS CUI [2,2])
Age
Item
4. male or female subjects, between the ages of 18 and 65 years old.
boolean
C0001779 (UMLS CUI [1])
Joint function Grade
Item
5. joint function grading and ray classification are both in ⅰ～ⅲ.
boolean
C1535551 (UMLS CUI [1,1])
C0441800 (UMLS CUI [1,2])
C0441800 (UMLS CUI [1,2])
Informed Consent
Item
6. subjects agree to participate in this study and sign the informed consent form.
boolean
C0021430 (UMLS CUI [1])
Lupus Erythematosus, Systemic | Sicca Syndrome | Severe osteoarthropathy
Item
1. subjects with systemic lupus erythematosus,sicca syndrome, or severe osteoarthropathy will be excluded.
boolean
C0024141 (UMLS CUI [1])
C0086981 (UMLS CUI [2])
C1969350 (UMLS CUI [3])
C0086981 (UMLS CUI [2])
C1969350 (UMLS CUI [3])
Rheumatoid Arthritis Severe
Item
2. subjects with severe rheumatic arthritis are loss of ability
boolean
C0003873 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0205082 (UMLS CUI [1,2])
Hypersensitivity Investigational New Drugs | Hypersensitivity Drug Combinations Investigational | Patient constitution allergic | Hypersensitivity Pharmaceutical Preparations Quantity
Item
3. allergic to test drugs(basic treatment or drug combination),allergic constitution(allergic to two or more drugs).
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0013162 (UMLS CUI [2,2])
C1517586 (UMLS CUI [2,3])
C0683521 (UMLS CUI [3,1])
C0700624 (UMLS CUI [3,2])
C0020517 (UMLS CUI [4,1])
C0013227 (UMLS CUI [4,2])
C1265611 (UMLS CUI [4,3])
C0013230 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0013162 (UMLS CUI [2,2])
C1517586 (UMLS CUI [2,3])
C0683521 (UMLS CUI [3,1])
C0700624 (UMLS CUI [3,2])
C0020517 (UMLS CUI [4,1])
C0013227 (UMLS CUI [4,2])
C1265611 (UMLS CUI [4,3])
Pregnancy | Breast Feeding | Pregnancy, Planned
Item
4. female subject who was pregnant or breast-feeding or considering becoming pregnant.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0032992 (UMLS CUI [3])
C0006147 (UMLS CUI [2])
C0032992 (UMLS CUI [3])
Cardiovascular Diseases Severe | Brain Diseases Severe | Lung diseases Severe | Liver diseases Severe | Kidney Diseases Severe | Hematopoietic System Disease Severe
Item
5. subjects with sever diseases in cardiovascular, brain, lung, liver, kidney and hematopoietic system.
boolean
C0007222 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0006111 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0024115 (UMLS CUI [3,1])
C0205082 (UMLS CUI [3,2])
C0023895 (UMLS CUI [4,1])
C0205082 (UMLS CUI [4,2])
C0022658 (UMLS CUI [5,1])
C0205082 (UMLS CUI [5,2])
C0018957 (UMLS CUI [6,1])
C0012634 (UMLS CUI [6,2])
C0205082 (UMLS CUI [6,3])
C0205082 (UMLS CUI [1,2])
C0006111 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0024115 (UMLS CUI [3,1])
C0205082 (UMLS CUI [3,2])
C0023895 (UMLS CUI [4,1])
C0205082 (UMLS CUI [4,2])
C0022658 (UMLS CUI [5,1])
C0205082 (UMLS CUI [5,2])
C0018957 (UMLS CUI [6,1])
C0012634 (UMLS CUI [6,2])
C0205082 (UMLS CUI [6,3])
Liver function | Alanine aminotransferase increased | Aspartate aminotransferase increased | Renal function | Blood urea increased | Serum creatinine raised
Item
6. the liver function (alt,ast) and kidney function（bun,cr）is higher than normal.
boolean
C0232741 (UMLS CUI [1])
C0151905 (UMLS CUI [2])
C0151904 (UMLS CUI [3])
C0232804 (UMLS CUI [4])
C0151539 (UMLS CUI [5])
C0700225 (UMLS CUI [6])
C0151905 (UMLS CUI [2])
C0151904 (UMLS CUI [3])
C0232804 (UMLS CUI [4])
C0151539 (UMLS CUI [5])
C0700225 (UMLS CUI [6])
Hematologic function | White blood cell count decreased | Decreased platelet count
Item
7. the blood routine (leukocyte count,platelet count)is lower than normal.
boolean
C0221130 (UMLS CUI [1])
C0750394 (UMLS CUI [2])
C0392386 (UMLS CUI [3])
C0750394 (UMLS CUI [2])
C0392386 (UMLS CUI [3])
Study Subject Participation Status Inappropriate
Item
8. subject considered by the investigator, for any reason, to be an unsuitable candidate for the study
boolean
C2348568 (UMLS CUI [1,1])
C1548788 (UMLS CUI [1,2])
C1548788 (UMLS CUI [1,2])